Unwanted after-effects at the site tissue was harvested from for a graft.
Donor-site morbidity refers to pain, weakness, sensory disturbance, scarring, or functional impairment arising from the site where autologous tissue (e.g., tendon, bone, skin, or nerve) was harvested for use elsewhere in a graft or reconstructive procedure. It is a key outcome measure in studies comparing graft techniques, since reducing harm at the donor site can offset the benefits of the reconstruction itself. Severity and duration are inconsistently defined and measured across the literature, so comparisons between studies should be made cautiously.
This guide was auto-drafted and is pending editorial review.